CONCORD, N.H. (AP) — Drugmaker Johnson & Johnson has agreed to pay $40.5 million in a settlement with New Hampshire over its role in the opioid addiction crisis, days before the case was scheduled for trial, the state attorney general’s …
OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the nation’s deadly opioid crisis that includes virtually all U.S. states and thousands of local governments, with the Sackler family members who own the company boosting their cash …
A Johnson & Johnson subsidiary came under attack in court on Monday for attempting to use the bankruptcy process to resolve tens of thousands of claims that its baby powder and other talc-based products caused cancer. The subsidiary, LTL Management, …
The three largest U.S. drug distributors and drugmaker Johnson & Johnson have agreed to pay $590 million to resolve claims by Native American tribes that the companies fueled an opioid epidemic in their communities, according to court filings. Tuesday’s deal …
Johnson & Johnson should know by the end of next month whether its controversial use of bankruptcy to try to resolve billions of dollars in cancer claims can proceed, or if the consumer products giant must fight roughly 38,000 lawsuits …
Johnson & Johnson on Friday said it had agreed to pay $44 million to resolve claims that it fueled the opioid epidemic in New Mexico, a state which originally opted against participating in a nationwide settlement resolving thousands of similar …
Johnson & Johnson disputed assertions that it was stalling and failing to cooperate in investigating claims related to its bankrupt talc unit, LTL Management LLC. “There was and continues to be no basis” for the talc claimants to demand that …
WASHINGTON — The U.S. Supreme Court on Monday declined to hear a bid by Johnson & Johnson to throw out a lawsuit brought by the state of Mississippi over allegations that the company failed to inform residents that its talc-based …
RARITAN, New Jersey–Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: People taking the company’s new blockbuster diabetes drug were falling gravely ill. The drug, Invokana, had been on the market less than …
The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson in a lawsuit by the state alleging the drugmaker fueled the opioid epidemic through the deceptive marketing of painkillers. The decision marked the latest setback …